ICD-10 Code B42.0 | Pulmonary sporotrichosis Symptoms, Diagnosis, Billing

Pulmonary sporotrichosis is a rare fungal infection caused by the Sporothrix schenckii species, primarily affecting the lungs. It is clinically significant due to its potential to cause severe respiratory symptoms and complications, particularly in immunocompromised individuals. The ICD-10 Code B42.0 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate management and resource allocation.

What is ICD-10 Code B42.0 for Pulmonary sporotrichosis?

ICD-10 Code B42.0 represents Pulmonary sporotrichosis, a fungal infection that primarily affects the lungs. This code should be used when documenting cases of pulmonary involvement due to Sporothrix schenckii, particularly in patients presenting with respiratory symptoms or complications. Accurate coding is essential for effective clinical documentation and appropriate billing practices.

ICD-10 Code B42.0 – Clinical Definition and Explanation of Pulmonary sporotrichosis

Pulmonary sporotrichosis is caused by the inhalation of spores from the Sporothrix schenckii fungus, which can lead to respiratory distress and systemic infection. The condition may progress rapidly, necessitating prompt medical intervention to prevent severe complications. Early recognition and treatment are crucial for favorable outcomes.

Key Clinical Features:

• Chronic cough, often productive of sputum
• Fever and night sweats
• Weight loss and fatigue
• Chest pain or discomfort

ICD-10 Code B42.0 for Pulmonary sporotrichosis – SOAP Notes & Clinical Use

ICD-10 Code B42.0 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of patients with pulmonary sporotrichosis. This code aids in capturing the patient's symptoms, guiding clinical decision-making, and ensuring appropriate management in both acute and chronic care settings.

What Does ICD-10 Code B42.0 for Pulmonary sporotrichosis Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B42.0 connects subjective reports of symptoms with objective clinical findings, facilitating a formal diagnosis of pulmonary sporotrichosis. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code B42.0 – Pulmonary sporotrichosis

Pulmonary sporotrichosis requires prompt medical attention, often necessitating hospitalization for severe cases. Treatment typically involves antifungal therapy and supportive care.

Antibiotic Therapy:

• Itraconazole: 200 mg daily for at least 6 months
• Fluconazole: 400 mg daily as an alternative
• Amphotericin B: for severe or disseminated cases

Supportive Care:

• Oxygen therapy for hypoxemia
• Bronchodilators for wheezing
• Fluid management and nutritional support

Infection Control:

• Implement standard precautions to prevent transmission
• Educate patients on hygiene practices
• Monitor for outbreaks in endemic areas

How to Document Symptoms of Pulmonary sporotrichosis (ICD-10 B42.0) in SOAP Notes

Subjective:

• Patient reports a persistent cough with greenish sputum.
• History of exposure to soil or decaying vegetation.
• Complaints of fever and night sweats over the past month.
• Notable weight loss of 10 pounds in the last month.

Objective:

• Auscultation reveals bilateral wheezing and crackles.
• Respiratory rate: 22 breaths per minute.
• Oxygen saturation: 92% on room air.
• Chest X-ray shows infiltrates consistent with fungal infection.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Pulmonary sporotrichosis (ICD-10 Code B42.0)

Assessment:

• Diagnosis: Pulmonary sporotrichosis, moderate severity.
• ICD-10 Code: B42.0.
• Contributing factors: Recent travel to endemic areas and exposure to soil.
• Consider differential diagnoses including other fungal infections.

Plan:

• Initiate itraconazole therapy at 200 mg daily.
• Educate patient on medication adherence and potential side effects.
• Schedule follow-up in 4 weeks to monitor response to treatment.
• Consider referral to infectious disease specialist if no improvement.

Treatment & Plan Section for ICD-10 Code B42.0 – Pulmonary sporotrichosis

• First-line treatment includes itraconazole or fluconazole.
• Non-pharmacologic strategies include smoking cessation and avoiding exposure to potential sources of infection.
• Monitoring includes regular follow-up visits and imaging to assess treatment response.
• Educate patients on recognizing worsening symptoms and when to seek care.

Using ICD-10 Code B42.0 for Pulmonary sporotrichosis in Billing & SOAP Note Compliance

• Select appropriate ICD-10 code based on clinical findings and documentation.
• Ensure Subjective (S) and Objective (O) sections clearly reflect the patient's symptoms and clinical status.
• Align treatment plans with clinical guidelines to support justified billing.
• Include relevant CPT codes for services rendered during the visit.

Related ICD-10 Codes Often Used with Pulmonary sporotrichosis

• B42.1 – Cutaneous sporotrichosis
• B42.9 – Sporotrichosis, unspecified
• B44.9 – Fungal infection, unspecified

ICD-10 Code B42.0 in Medical Billing and Insurance for Pulmonary sporotrichosis

ICD-10 Code B42.0 is crucial for billing in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services rendered.

Billing Notes:

• Document all relevant clinical findings to support the use of B42.0.
• Use this code in conjunction with other relevant codes for comprehensive billing.
• Ensure that the diagnosis is clearly linked to the treatment provided in the medical record.
• Review payer-specific guidelines for any additional documentation requirements.

Common CPT Pairings: